JP2011500586A5 - - Google Patents

Download PDF

Info

Publication number
JP2011500586A5
JP2011500586A5 JP2010529054A JP2010529054A JP2011500586A5 JP 2011500586 A5 JP2011500586 A5 JP 2011500586A5 JP 2010529054 A JP2010529054 A JP 2010529054A JP 2010529054 A JP2010529054 A JP 2010529054A JP 2011500586 A5 JP2011500586 A5 JP 2011500586A5
Authority
JP
Japan
Prior art keywords
group
membered heterocyclic
hydrogen
alkyl
aromatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010529054A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011500586A (ja
JP5733856B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/079410 external-priority patent/WO2009049086A1/en
Publication of JP2011500586A publication Critical patent/JP2011500586A/ja
Publication of JP2011500586A5 publication Critical patent/JP2011500586A5/ja
Application granted granted Critical
Publication of JP5733856B2 publication Critical patent/JP5733856B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010529054A 2007-10-09 2008-10-09 広帯域β−ラクタマーゼ阻害薬 Expired - Fee Related JP5733856B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US99794107P 2007-10-09 2007-10-09
US99789807P 2007-10-09 2007-10-09
US60/997,941 2007-10-09
US60/997,898 2007-10-09
PCT/US2008/079410 WO2009049086A1 (en) 2007-10-09 2008-10-09 Broad spectrum beta-lactamase inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015081763A Division JP2015155435A (ja) 2007-10-09 2015-04-13 広帯域β−ラクタマーゼ阻害薬

Publications (3)

Publication Number Publication Date
JP2011500586A JP2011500586A (ja) 2011-01-06
JP2011500586A5 true JP2011500586A5 (https=) 2012-09-13
JP5733856B2 JP5733856B2 (ja) 2015-06-10

Family

ID=40549565

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2010529054A Expired - Fee Related JP5733856B2 (ja) 2007-10-09 2008-10-09 広帯域β−ラクタマーゼ阻害薬
JP2015081763A Pending JP2015155435A (ja) 2007-10-09 2015-04-13 広帯域β−ラクタマーゼ阻害薬
JP2017106751A Pending JP2017193558A (ja) 2007-10-09 2017-05-30 広帯域β−ラクタマーゼ阻害薬
JP2018139646A Pending JP2018193388A (ja) 2007-10-09 2018-07-25 広帯域β−ラクタマーゼ阻害薬

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2015081763A Pending JP2015155435A (ja) 2007-10-09 2015-04-13 広帯域β−ラクタマーゼ阻害薬
JP2017106751A Pending JP2017193558A (ja) 2007-10-09 2017-05-30 広帯域β−ラクタマーゼ阻害薬
JP2018139646A Pending JP2018193388A (ja) 2007-10-09 2018-07-25 広帯域β−ラクタマーゼ阻害薬

Country Status (5)

Country Link
US (6) US8883772B2 (https=)
EP (1) EP2209474A4 (https=)
JP (4) JP5733856B2 (https=)
CA (2) CA2935651A1 (https=)
WO (1) WO2009049086A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050227309A1 (en) 2004-01-21 2005-10-13 Corry Schuyler B Optically-detectable enzyme substrates and their method of use
EP2209474A4 (en) 2007-10-09 2013-07-24 Sopharmia Inc BROAD SPECTRUM BETA-LACTAMASE INHIBITORS
WO2013036783A2 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
JP6403289B2 (ja) * 2013-03-12 2018-10-10 グラディウス ファーマシューティカルズ コーポレーションＧｌａｄｉｕｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｏｒｐｏｒａｔｉｏｎ 誘導体化３−スチリル−セファロスポリン
CN104805066B (zh) * 2015-05-18 2018-04-24 武汉菲吉乐科生物科技有限公司 一种葡萄球菌裂解酶及其应用
US20190100534A1 (en) * 2017-10-04 2019-04-04 Gladius Pharmaceuticals, Inc. Cephem Compounds with Latent Reactive Groups
EP3795149A4 (en) 2018-05-14 2022-01-05 National University Corporation Tokai National Higher Education and Research System BETA-LACTAMASE INHIBITOR
WO2020018462A1 (en) 2018-07-16 2020-01-23 Brown University A chromogenic beta-lactamase substrate
US12195755B2 (en) 2019-05-20 2025-01-14 Brown University Placental lipid bilayer for cell-free molecular interaction studies
US12509559B2 (en) 2019-10-28 2025-12-30 Brown University Bacterial beta-lactamase responsive hydrogels
WO2024160247A1 (zh) * 2023-02-02 2024-08-08 苏州信诺维医药科技股份有限公司 含β-内酰胺酶抑制剂的药物组合物及其应用

Family Cites Families (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130098C (https=) 1963-07-15
US3971778A (en) * 1972-05-12 1976-07-27 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino)acylamido groups at the 7-position
US4065620A (en) * 1971-06-14 1977-12-27 Eli Lilly And Company 3-(Substituted) vinyl cephalosporins
BE789817A (fr) * 1971-10-07 1973-04-06 Glaxo Lab Ltd Perfectionnements aux composes de cephalosporine
US3947413A (en) 1972-11-13 1976-03-30 Merck & Co., Inc. 3-α-Substituted cephalosporins
US4095021A (en) * 1973-12-21 1978-06-13 Glaxo Laboratories Limited 3-Carbamoyloxymethyl or N-methyl-carbamoyloxymethyl-7-[2-carboxymethoxyimino-2-(fur-2-yl or thien-2-yl)acetamido]ceph-3-em-4-carboxylic acids and derivatives thereof
DE2418841C3 (de) 1974-04-19 1979-04-26 Messerschmitt-Boelkow-Blohm Gmbh, 8000 Muenchen Wärmetauscher, insbesondere regenerativ gekühlte Brennkammern für Flüssigkeitsraketentriebwerke und Verfahren zu ihrer Herstellung
CA1136132A (en) * 1975-02-17 1982-11-23 Teruji Tsuji Cyclization to form cephem ring and intermediates therefor
US3983113A (en) * 1975-08-15 1976-09-28 Syntex (U.S.A.) Inc. Cephalosporin type antibacterials
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4094978A (en) * 1976-07-29 1978-06-13 Syntex (U.S.A.) Inc. 3-propenyl derivatives of cephalosporin, compositions and their use
JPS5331690A (en) 1976-09-01 1978-03-25 Shionogi & Co Ltd Oxadithiacephalosporins
JPS6011713B2 (ja) 1976-09-08 1985-03-27 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法
LU77306A1 (https=) * 1977-05-09 1979-01-18
US4500457A (en) * 1977-05-09 1985-02-19 Ciba-Geigy Corporation Process for preparing thia-aza compounds with a beta-lactam ring
US4255423A (en) * 1977-07-27 1981-03-10 Merck & Co., Inc. Cephalosporin compounds
EP0003960B1 (de) * 1978-02-02 1983-06-29 Ciba-Geigy Ag 6-Substituierte Thia-Azaverbindungen, ihre Herstellung und diese enthaltende pharmazeutische Präparate
AR228726A1 (es) 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
FR2457296A1 (fr) * 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouveaux derives de vinyl-3 cephalosporines et leur preparation
FR2474504A1 (fr) * 1979-05-23 1981-07-31 Rhone Poulenc Ind Nouvelles thiovinyl-3 cephalosporines, leur preparation et les medicaments qui les contiennent
CH645117A5 (fr) * 1979-05-23 1984-09-14 Rhone Poulenc Ind Thiovinyl-3 cephalosporines, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2457297A1 (fr) * 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouvelles vinyl-3 cephalosporines, et leur preparation
US4388326A (en) * 1979-08-15 1983-06-14 Merck & Co., Inc. Phenyl hydroxypropyl sulfoxide enzyme inhibitors
US4558071A (en) * 1979-08-15 1985-12-10 Merck & Co., Inc. Phenyl, trihalomethyl or heteroaryl sulfoxides having a latent allyl group bound to sulfur as enzyme inhibitors
US4342758A (en) * 1979-08-15 1982-08-03 Merck & Co., Inc. Allylsulfoxide enzyme inhibitors
PT71651B (en) 1979-08-15 1982-01-21 Merck & Co Inc Process for preparing allysulfoxide enzyme inhibitors
US4654359A (en) * 1979-08-15 1987-03-31 Merck & Co., Inc. Allylsulfoxide enzyme inhibitors
US4760067A (en) * 1979-08-15 1988-07-26 Merck & Co., Inc. Allylsulfoxide enzyme inhibitors
NL8100539A (nl) * 1980-02-12 1981-09-01 Rhone Poulenc Ind Nieuwe thiolesters, de bereiding daarvan en hun gebruik bij syntheses.
FR2494280A1 (fr) 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de la cephalosporine et leur preparation
US4380512A (en) * 1980-12-11 1983-04-19 Bristol-Myers Company 2β-Chloromethyl-2α-methylpenam-3α-carboxylic acid sulfone and salts and esters thereof
US4382931A (en) 1981-09-08 1983-05-10 Eli Lilly And Company 3'-Substituted quinolinium cephalosporins
US4546101A (en) * 1982-09-10 1985-10-08 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds useful for treating infectious diseases in human being and animals and processes for preparation thereof
GB8301694D0 (en) 1983-01-21 1983-02-23 Beecham Group Plc Beta-lactam antibacterial agents
US4520022A (en) * 1983-01-28 1985-05-28 Bristol-Myers Company Substituted vinyl cephalosporins
US4855420A (en) 1983-06-03 1989-08-08 Ici Pharma Cephalosporin derivatives
EP0133670A3 (de) * 1983-08-09 1985-12-18 Bayer Ag Verfahren zur Herstellung von 7-Acylamino-3-hydrocy-cephem-4-carbonsäuren und 7-Acylamino-3-hydroxy-1-de-thia-1-oxacephem-4-carbonsäuren
JPS60197693A (ja) 1984-03-19 1985-10-07 Eisai Co Ltd ３−（キヌクリジニウム）メチル−３−セフエム誘導体
IE58487B1 (en) * 1984-09-07 1993-09-22 Kaisha Maiji Seika New cephalosporin compounds and the production thereof
JPS61178991A (ja) * 1984-09-07 1986-08-11 Meiji Seika Kaisha Ltd 新規セフアロスポリン化合物
US4874856A (en) 1985-06-24 1989-10-17 Bristol-Myers Company 3-(substituted)propenyl-7-(aminothiazolylacetamido) ceph-3-em-4-carboxylic acids and esters thereof
US4692517A (en) 1986-03-20 1987-09-08 American Home Products Corporation C-3' acylaminooxy-7-[(2-aminothiazol-4-yl)-α-(substituted-oximino)acetyl]cephalosporin derivatives
JPS62270589A (ja) 1986-05-19 1987-11-24 Banyu Pharmaceut Co Ltd 新規セフアロスポリン誘導体
US4870168A (en) * 1987-02-26 1989-09-26 Bristol-Myers Company 3-Unsaturated alkyl cephems from 3-triflyl cephems
JPS63211286A (ja) 1987-02-27 1988-09-02 Sagami Chem Res Center β−ラクタム誘導体
DE3734004A1 (de) 1987-05-26 1988-12-15 Bayer Ag Substituierte vinylcephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US5171854A (en) * 1987-05-26 1992-12-15 Bayer Aktiengesellschaft Substituted vinylcephalosporins
DE3734005A1 (de) 1987-05-26 1988-12-15 Bayer Ag Substituierte vinylcephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JPH01175982A (ja) 1987-12-28 1989-07-12 Mochida Pharmaceut Co Ltd 新規セファロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
US5073551A (en) * 1988-03-30 1991-12-17 Sagami Chemical Research Center Cephalosporin compounds
US5336768A (en) * 1988-05-24 1994-08-09 Hoffmann-La Roche Inc. Antibacterial cephalosporin compounds
JPH0228185A (ja) 1988-04-14 1990-01-30 Tanabe Seiyaku Co Ltd セファロスポリン化合物及びその合成中間体
GB8813945D0 (en) 1988-06-13 1988-07-20 Fujisawa Pharmaceutical Co New cephem compounds & process for preparation thereof
JPH0686463B2 (ja) * 1988-07-01 1994-11-02 明治製菓株式会社 新規セフェム化合物、その製造法及び抗菌剤
GB8817653D0 (en) 1988-07-25 1988-09-01 Fujisawa Pharmaceutical Co New cephem compounds & processes for preparation thereof
JPH0635464B2 (ja) * 1988-09-02 1994-05-11 明治製菓株式会社 新規セフェム化合物、その製造法及び抗菌剤
JPH0699448B2 (ja) 1989-02-22 1994-12-07 明治製菓株式会社 新規セファロスポリン化合物及び抗菌剤
JP2834771B2 (ja) * 1989-06-02 1998-12-14 エーザイ株式会社 チアゾリルアセトアミドセフェム誘導体
IL94946A0 (en) * 1989-07-13 1991-06-10 Eisai Co Ltd 3-substituted vinyl cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
US5143910A (en) 1989-09-07 1992-09-01 Shionogi & Co., Ltd. Piperaziniocephalosporins
US5373001A (en) * 1990-06-15 1994-12-13 Roussel Uclaf Cephalosporins
US5397779A (en) * 1990-06-15 1995-03-14 Roussel-Uclaf Cephalosporins
US5126336A (en) 1990-08-23 1992-06-30 Bristol-Myers Squibb Company Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof
JPH04112891A (ja) 1990-09-04 1992-04-14 Ajinomoto Co Inc 新規オキシム誘導体及び該誘導体を含有する抗菌剤
DE4030706A1 (de) 1990-09-28 1992-04-02 Bayer Ag Neue 3-substituierte cephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US5194433A (en) 1990-11-13 1993-03-16 Bristol-Myers Squibb Company Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof
ES2157199T3 (es) 1991-03-08 2001-08-16 Biochemie Gmbh Nuevo procedimiento para la produccion de cefalosporinas y nuevos compuestos intermedios para este procedimiento.
US6248881B1 (en) * 1991-03-08 2001-06-19 Biochemie Gmbh Intermediates and process for the production of 3-vinyl cephalosporins
GB9111406D0 (en) 1991-05-28 1991-07-17 Fujisawa Pharmaceutical Co New cephem compounds and processes for preparation thereof
GB9118672D0 (en) 1991-08-30 1991-10-16 Fujisawa Pharmaceutical Co New cephem compounds and processes for preparation thereof
EP0544166A3 (en) 1991-11-26 1993-11-03 Hoffmann La Roche Cephalosporinderivatives
ATE208374T1 (de) 1992-02-18 2001-11-15 Otsuka Kagaku Kk Beta-laktam und cepham verbindungen und ihre herstellung
JP3224279B2 (ja) * 1992-07-27 2001-10-29 大塚化学株式会社 セフエム化合物の製造法
JPH06145176A (ja) 1992-11-10 1994-05-24 Kyoto Yakuhin Kogyo Kk セファロスポリン化合物、その製造法および中間体化合物
AU6291194A (en) * 1993-03-26 1994-10-24 Yamanouchi Pharmaceutical Co., Ltd. Cephalosporin derivative
JPH06345775A (ja) 1993-06-04 1994-12-20 Kyoto Yakuhin Kogyo Kk セファロスポリン化合物、その製造法および中間体化合物
KR100257130B1 (ko) * 1993-09-11 2000-05-15 성재갑 신규 세팔로스포린계 항생제 및 이의 제조방법
US5854227A (en) 1994-03-04 1998-12-29 Hartmann; John F. Therapeutic derivatives of diphosphonates
JPH093074A (ja) 1995-06-20 1997-01-07 Kyoto Yakuhin Kogyo Kk セファロスポリン化合物、その用途および中間体化合物
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
CN1239963A (zh) 1996-12-09 1999-12-29 明治制果株式会社 新的头孢烯衍生物
JP4157177B2 (ja) * 1997-06-04 2008-09-24 大塚化学ホールディングス株式会社 ３−アルケニルセフェム化合物の製造法
ES2258980T3 (es) * 1999-08-16 2006-09-16 Revaax Pharmaceuticals Llc Composiciones farmaceuticas que comprenden acido clavulanico o derivados del mismo para el tratamiento de trastornos del comportamiento.
JP4510957B2 (ja) * 1999-09-01 2010-07-28 大塚化学株式会社 セフェム化合物の製造方法
AU9025601A (en) * 2000-09-22 2002-04-02 Zenyaku Kogyo Kabushiki Kaisya Cephem compounds and esbl-detecting reagents containing the same
TW200305422A (en) 2002-03-18 2003-11-01 Shionogi & Co Broad spectrum cefem compounds
CA2504730C (en) 2002-10-30 2011-04-12 Astellas Pharma Inc. Cephem compounds
EP1635812A2 (en) * 2003-06-10 2006-03-22 Fulcrum Pharmaceuticals, Inc. Beta-lactamase inhibitors and methods of use thereof
CN100384857C (zh) 2003-11-28 2008-04-30 浙江永宁制药厂 耐β-内酰胺酶的头孢菌素酯化合物及其盐
WO2007065288A2 (en) 2005-12-07 2007-06-14 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
WO2007096740A2 (en) 2006-02-20 2007-08-30 Orchid Research Laboratories Limited Novel cephalosporins
JP2009530228A (ja) 2006-03-16 2009-08-27 アステラス製薬株式会社 セフェム化合物および抗菌薬としての利用
EP2209474A4 (en) 2007-10-09 2013-07-24 Sopharmia Inc BROAD SPECTRUM BETA-LACTAMASE INHIBITORS
US9238657B2 (en) 2008-10-31 2016-01-19 Shionogi & Co., Ltd. Cephalosporin having catechol group
US20100261700A1 (en) * 2009-04-09 2010-10-14 Larry Sutton Beta-lactamase inhibitors
US20120329770A1 (en) 2010-02-26 2012-12-27 Gary Igor Dmitrienko Cephalosporin derivatives useful as beta-lactamase inhibitors and compositions and methods of use thereof
KR20130018845A (ko) 2010-04-05 2013-02-25 시오노기세야쿠 가부시키가이샤 카테콜기를 갖는 세펨 화합물
CN102918047A (zh) 2010-04-05 2013-02-06 盐野义制药株式会社 具有假儿茶酚基团的头孢烯类化合物
US9085589B2 (en) 2010-04-28 2015-07-21 Shionogi & Co., Ltd. Cephem derivative
KR101719556B1 (ko) 2011-03-30 2017-03-24 주식회사 레고켐 바이오사이언스 신규한 세파로스포린 유도체 및 이를 함유하는 의약 조성물
US9334289B2 (en) 2011-04-28 2016-05-10 Shionogi & Co., Ltd. Cephem compound having catechol or pseudo-catechol structure
WO2013051597A1 (ja) 2011-10-04 2013-04-11 塩野義製薬株式会社 カテコール基を有するセフェム誘導体
TWI547496B (zh) 2011-10-04 2016-09-01 葛蘭素集團公司 抗菌化合物
JP6403289B2 (ja) 2013-03-12 2018-10-10 グラディウス ファーマシューティカルズ コーポレーションＧｌａｄｉｕｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｏｒｐｏｒａｔｉｏｎ 誘導体化３−スチリル−セファロスポリン

Similar Documents

Publication Publication Date Title
JP2011500586A5 (https=)
LTC2228064I2 (lt) Farmacinė kompozicija, kurios sudėtyje yra glikopirolatas ir beta-2 adrenoceptorinis antagonistas
JP2010506942A5 (https=)
BRPI0608732A2 (pt) composto ou um sal, hidrato, solvato, complexo ou pró-droga farmaceuticamente aceitável do mesmo, sal de um composto, processo para a preparação de um composto, uso de um composto, composição farmacêutica, e, produto
NO20065613L (no) 3-karbamoyl-2-pyridonderivat.
EP2520567A3 (en) Nitrogen-containing heterocycle derivatives substituted with cyclic group
TW200716528A (en) Cyclopropanecarboxamide derivatives
EA200500814A1 (ru) Производные пирролопиримидина
TW200833675A (en) Nicotinamide derivatives
MY138420A (en) Indole derivative having piperidine ring
ATE457988T1 (de) A2a-adenosin-rezeptor-antagonisten
PL1891029T3 (pl) Związki organiczne do leczenia stanów zapalnych lub alergicznych
JP2008546770A5 (https=)
RU2314292C2 (ru) Производные азетидина в качестве антагонистов ccr-3 рецептора
WO2008157404A3 (en) Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
DE602004020730D1 (de) Pharmazeutisches verfahren und damit hergestellte verbindungen
DE602005019316D1 (en) Aromatische etherderivate als thrombin-hemmer
MX2025010256A (es) Derivados de hidroquinazolina para el tratamiento de una enfermedad o un trastorno
WO2009009531A3 (en) Pyrimidinecarboxamide derivatives for the treatment of hiv infections
AU2004216182A1 (en) Selective non-steroidal glucocorticoid receptor modulators
EA200701035A1 (ru) Замещенные n-сульфониламинобензил-2-феноксиацетамидные соединения
JP2016512541A5 (https=)
JP2011508779A5 (https=)
ATE409179T1 (de) Tetralin- und indanderivate und deren anwendungen als 5-ht-antagonisten
MY140325A (en) Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them